The 13th International Pharmacy and Medicine Conference ICPM 2025 revealed the establishment of three new pharmaceutical ...

To access the live webcast and archived recording of the event, visit the Events & Presentations section of the Phathom website at ...

The life-sciences company expects its capsules and health business to return to growth in 2025, after sales and earnings fell ...

The fund will seek a total of roughly ¥11 billion in damages from former Chairman Kazumasa Kobayashi and six then-board ...

Under the UK's Pharmacy First initiative, people are encouraged to see their pharmacist before consulting their GP—especially ...

Amneal Pharmaceuticals Inc ... has approved CREXONT® (carbidopa and levodopa) extended-release capsules for the treatment of Parkinson’s disease (PD). CREXONT is a novel, oral formulation ...

Some supplements claim they have ingredients that help you go to the bathroom less. Here’s what the science says about their ...

Newbury Pharmaceuticals is pleased to announce the successful Marketing Authorization (MA) of Pomalidomide Newbury in Denmark as the first country in a Scandinavian registration procedure. Approvals i ...

The 13th International Pharmacy and Medicine Conference (ICPM 2025) revealed the establishment of three new pharmaceutical ...

The global enteric softgel capsules market is poised for significant growth, according to recent research by Future Market ...

Amneal Pharmaceuticals (AMRX) announced that the FDA has approved memantine/donepezil 14-10 mg and 28-10 mg extended-release capsules, which ...

As part of the regulatory action, memantine/donepezil extended-release capsules have been granted a 180-day exclusivity in ...